Insights into the Worldwide Artificial Intelligence in Drug Discovery Industry to 2026 - Featuring Atomwise, BenevolentAI & Berg Among Others - ResearchAndMarkets.com
Summary
DUBLIN--(BUSINESS WIRE)--The "Global Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Region: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.coms offering. The global artificial intelligence (AI) in drug discovery market will reach $2.57 billion by 2026, growing by 30.3% annually over 2020-2026 despite the COVID-19 impact. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. In-depth qualitative analyses include identification and investigation of the following aspects: The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.